Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.
<h4>Background and objective</h4>The necessity of therapeutic drug monitoring (TDM) for vancomycin is controversial. The objective of the current review was to evaluate the available evidence for the necessity of TDM in patients given vancomycin to treat Gram-positive infections.<h4&g...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0077169&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850116022499016704 |
|---|---|
| author | Zhi-Kang Ye Hui-Lin Tang Suo-Di Zhai |
| author_facet | Zhi-Kang Ye Hui-Lin Tang Suo-Di Zhai |
| author_sort | Zhi-Kang Ye |
| collection | DOAJ |
| description | <h4>Background and objective</h4>The necessity of therapeutic drug monitoring (TDM) for vancomycin is controversial. The objective of the current review was to evaluate the available evidence for the necessity of TDM in patients given vancomycin to treat Gram-positive infections.<h4>Methods</h4>Medline, Embase, Web of Sciences, the Cochrane Library and two Chinese literature databases (CNKI, CBM) were searched. Randomized controlled studies and observational studies that compared the clinical outcomes of TDM groups vs. non-TDM groups were included. Two reviewers independently extracted the data. The primary outcome was clinical efficacy of therapy. Secondary outcomes included vancomycin associated nephrotoxicity, duration of vancomycin therapy, length of hospital stay, and mortality. Meta-analysis was performed using the Mantel-Haenszel fixed effect method (FEM). Odds ratios (ORs) or weighted mean differences (WMD) with 95% confidence intervals (95%CIs) were calculated for categorical and continuous outcomes, respectively.<h4>Results</h4>One randomized controlled trial (RCT) and five cohort studies were included in the meta-analysis. Compared with non-TDM groups, TDM groups had significantly higher rates of clinical efficacy (OR = 2.62, 95%CI 1.34-5.11 P = 0.005) and decreased rates of nephrotoxicity (OR = 0.25, 95%CI 0.13-0.48 P<0.0001). Subgroup analyses showed that TDM group had significantly higher rates of clinical efficacy in both cohort studies subgroup (OR = 3.04, 95%CI 1.34-6.90) and in Asian population subgroup (OR = 3.04, 95%CI 1.34-6.90). TDM group had significantly decreased rates of nephrotoxicity in all subgroup. There was no significant difference in duration of vancomycin therapy (WMD = -0.40, 95%CI -2.83-2.02 P = 0.74) or length of stay (WMD = -1.01, 95%CI -7.51-5.49 P = 0.76) between TDM and non-TDM groups. Subgroup analyses showed there were no differences in duration of vancomycin therapy. Only one study reported mortality rates.<h4>Conclusions</h4>Studies to date show that TDM significantly increases the rate of clinical efficacy and decreases the rate of nephrotoxicity in patients treated with vancomycin. |
| format | Article |
| id | doaj-art-e81a8dd28a8d49988971813d5430aa35 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e81a8dd28a8d49988971813d5430aa352025-08-20T02:36:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7716910.1371/journal.pone.0077169Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.Zhi-Kang YeHui-Lin TangSuo-Di Zhai<h4>Background and objective</h4>The necessity of therapeutic drug monitoring (TDM) for vancomycin is controversial. The objective of the current review was to evaluate the available evidence for the necessity of TDM in patients given vancomycin to treat Gram-positive infections.<h4>Methods</h4>Medline, Embase, Web of Sciences, the Cochrane Library and two Chinese literature databases (CNKI, CBM) were searched. Randomized controlled studies and observational studies that compared the clinical outcomes of TDM groups vs. non-TDM groups were included. Two reviewers independently extracted the data. The primary outcome was clinical efficacy of therapy. Secondary outcomes included vancomycin associated nephrotoxicity, duration of vancomycin therapy, length of hospital stay, and mortality. Meta-analysis was performed using the Mantel-Haenszel fixed effect method (FEM). Odds ratios (ORs) or weighted mean differences (WMD) with 95% confidence intervals (95%CIs) were calculated for categorical and continuous outcomes, respectively.<h4>Results</h4>One randomized controlled trial (RCT) and five cohort studies were included in the meta-analysis. Compared with non-TDM groups, TDM groups had significantly higher rates of clinical efficacy (OR = 2.62, 95%CI 1.34-5.11 P = 0.005) and decreased rates of nephrotoxicity (OR = 0.25, 95%CI 0.13-0.48 P<0.0001). Subgroup analyses showed that TDM group had significantly higher rates of clinical efficacy in both cohort studies subgroup (OR = 3.04, 95%CI 1.34-6.90) and in Asian population subgroup (OR = 3.04, 95%CI 1.34-6.90). TDM group had significantly decreased rates of nephrotoxicity in all subgroup. There was no significant difference in duration of vancomycin therapy (WMD = -0.40, 95%CI -2.83-2.02 P = 0.74) or length of stay (WMD = -1.01, 95%CI -7.51-5.49 P = 0.76) between TDM and non-TDM groups. Subgroup analyses showed there were no differences in duration of vancomycin therapy. Only one study reported mortality rates.<h4>Conclusions</h4>Studies to date show that TDM significantly increases the rate of clinical efficacy and decreases the rate of nephrotoxicity in patients treated with vancomycin.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0077169&type=printable |
| spellingShingle | Zhi-Kang Ye Hui-Lin Tang Suo-Di Zhai Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PLoS ONE |
| title | Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. |
| title_full | Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. |
| title_fullStr | Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. |
| title_full_unstemmed | Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. |
| title_short | Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. |
| title_sort | benefits of therapeutic drug monitoring of vancomycin a systematic review and meta analysis |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0077169&type=printable |
| work_keys_str_mv | AT zhikangye benefitsoftherapeuticdrugmonitoringofvancomycinasystematicreviewandmetaanalysis AT huilintang benefitsoftherapeuticdrugmonitoringofvancomycinasystematicreviewandmetaanalysis AT suodizhai benefitsoftherapeuticdrugmonitoringofvancomycinasystematicreviewandmetaanalysis |